GDRX
Goodrx Holdings Inc
3.30$
+0.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -73.7% | +168.4% | -77.2% | +795.4% | -48.5% | -79.0% | +426.7% | +53.3% | -56.7% | -64.0% | +582.8% | – | |
| – | +32.0% | -63.4% | +6.4% | +3.4% | +8.9% | +9.5% | -5.7% | +8.6% | +8.0% | -5.8% | +2.2% | – | |
| – | -11.8% | -12.8% | +6.0% | -0.8% | -20.6% | -8.5% | +11.7% | -15.4% | -1.1% | -7.9% | +0.5% | – | |
| – | -268.0% | – | -5,240.5% | – | -78.9% | -731.1% | – | – | -209.7% | – | – | – | |
| – | -5.7% | +60.2% | -16.4% | -97.7% | +4,030.0% | +31.4% | -16.3% | -1.7% | -12.1% | +36.7% | -98.3% | – | |
| – | -5.7% | +60.2% | -16.4% | -8.0% | +4.9% | +211.7% | -64.7% | -1.7% | +76.5% | -31.9% | -33.4% | – | |
| – | +40.6% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +909.1% | +96.9% | -94.0% | -40.7% | -96.5% | +53,036.7% | -54.0% | +32.8% | -84.6% | +33.3% | -84.5% | – | |
| – | – | – | – | – | -100.0% | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | – | |
| – | +816.4% | +28.2% | -99.5% | +19,822.3% | -97.9% | +2,871.7% | -51.5% | +29.2% | -80.5% | +27.1% | -63.1% | – | |
| – | -472.5% | – | – | – | – | -699.8% | – | – | – | – | – | – | |
| – | -93.6% | +633.3% | -134.3% | – | -67.5% | -144.4% | – | +85.6% | -70.6% | -157.5% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.